Cargando…
Real-World Experience Treating Pediatric Epilepsy Patients With Cenobamate
INTRODUCTION: In one third of all patients with epilepsy, seizure freedom is not achieved through anti-seizure medication (ASM). These patients have an increased risk of earlier death, poorer cognitive development, and reduced quality of life. Cenobamate (CNB) has recently been approved as a promisi...
| Autores principales: | , , , , , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Frontiers Media S.A.
2022
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9350548/ https://www.ncbi.nlm.nih.gov/pubmed/35937072 http://dx.doi.org/10.3389/fneur.2022.950171 |